Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Sevan Antreasyan
Implications for intellectual property rights following Switzerland and India’s new free trade agreement
Negotiations EFTA Lexology | 25 March 2024 Implications for intellectual property rights following Switzerland and India’s new free trade agreement by Peter Ling, Thierry Calame, Jürg Simon and Sevan Antreasyan - Lenz & Staehelin On March 10 2024, Switzerland – together with fellow European Free Trade Association members Liechtenstein, Norway and Iceland – signed the ‘Trade and Economic Partnership Agreement’ (Free Trade Agreement, "FTA") with India.
Interchangeability And Incentives - Switzerland Aims At Encouraging Use Of Biosimilars And Generics - Healthcare - Switzerland
The Swiss government wants to encourage the use of biosimilars and generics with the aim of decreasing the costs of healthcare. Recent regulatory and legislative changes will make it easier to replace reference products by biosimilars and incentivize patients to choose generics and biosimilars when available.
Interchangeability and Incentives - Switzerland Aims at Encouraging Use of Biosimilars and Generics
The Swiss government wants to encourage the use of biosimilars and generics with the aim of decreasing the costs of healthcare. Recent regulatory and legislative changes will make it easier to replace reference products by biosimilars and incentivize patients to choose generics and biosimilars when available. A.
Greenwashing: Green Claims In Commercial Communications
The June 2023 ruling by the Swiss Commission for Fairness, finding FIFA's communications on carbon neutrality at the World Cup 2022 misleading to consumers, has attracted global attention. This decision acts as a strong reminder for companies to carefully evaluate their commercial communications, ensuring verifiable evidence supports environmental assertions.
Le règlement de l'UE sur les subventions étrangères : Implications pour les entreprises en Suisse
A partir du 12 juillet 2023, le Foreign Subsidies Regulation (FSR) s'appliquera. La Commission européenne pourra désormais examiner les concentrations qui atteignent les seuils de notification pour déterminer si des subventions provenant d'États non membres de l'UE faussent le marché intérieur. Cet examen s'ajoute aux procédures de contrôle de concentrations et d'examen des investissements étrangers.
The EU Foreign Subsidies Regulation: Implications for Companies in Switzerland
As of July 12, 2023, the European Foreign Subsidies Regulation (FSR) will apply. The European Commission can now examine concentrations that meet the filing thresholds for subsidies from non-EU Member States distorting the internal market. This review is in addition to the merger control procedures and foreign investment screenings. The FSR also introduces a comprehensive subsidy control for public procurement procedures.
Die EU Foreign Subsidies Regulation: Implikationen für Unternehmen in der Schweiz
Ab dem 12. Juli 2023 gilt die europäische Foreign Subsidies Regulation (FSR). Die EUKommission kann neu meldepflichtige Unternehmenszusammenschlüsse auf wettbewerbsverzerrende Subventionen aus Nicht-EU-Ländern prüfen. Diese Prüfung tritt zu der wettbewerbsrechtlichen Fusionskontrolle und den Investitionskontrollverfahren hinzu. Mit der FSR wird zudem eine weitreichende Subventionskontrolle im Vergaberecht eingeführt.
Competition law: Swiss Competition Commission issues revised vertical notice
The Swiss Competition Commission issued its revised notice on the treatment of vertical agreements under competition law. It will enter into force on January 1, 2023. The revised Notice is based on the EU Verticals Block Exemption Regulation, but contains a "Swiss Finish" in key aspects.
Droit de la distribution: la Commission de la concurrence suisse révise sa Communication sur les accords verticaux
La Commission de la concurrence suisse a adopté sa Communication concernant l'appréciation des accords verticaux révisée. Elle entrera en vigueur le 1er janvier 2023. La Communication révisée se base sur le règlement d'exemption par catégorie applicable aux accords verticaux de l'UE, mais intègre un "Swiss Finish" concernant certains aspects essentiels.
Vertriebskartellrecht: Schweizer Wettbewerbskommission erlässt revidierte Vertikalbekanntmachung
Die Schweizer Wettbewerbskommission hat ihre revidierte Bekanntmachung über die wettbewerbsrechtliche Behandlung von Vertikalabreden verabschiedet. Sie wird am 1. Januar 2023 in Kraft treten. Die revidierte Bekanntmachung orientiert sich an der EU Vertikal-GVO, enthält aber in wesentlichen Aspekten einen "Swiss Finish". Ausgangslage Die Schweizer Wettbewerbskommission ("WEKO") hat am 14.
Software as a medical device - Swiss Federal Administrative Court confirms fertility tracker app is a medical device
In a recent decision, the Swiss Federal Administrative Court (FAC) confirms that a mobile application intended to monitor fertility qualifies as a medical device used for contraception subject to a certification procedure with a notified body. This ruling confirms the alignment of the classification of contraception apps between Swiss and European authorities. 1.
Competition Law: Revision Of The Swiss Vertical Notice - Antitrust, EU Competition - Switzerland
Following the revision of the Vertical Block Exemption Regulation in the European Union, the Swiss Competition Commission is now also proposing to amend its Vertical Notice and Guidelines. Although the proposed amendments are based on the new EU distribution rules, they still depart from them on key issues, resulting in a "Swiss Finish".
WTO Adopts Compromise On The Waiver Of Patent Rights To Address COVID-19 Pandemic
On 17 June 2022, the Ministerial Conference, the topmost decision-making body of the World Trade Organization ("WTO"), adopted a Decision (Document WT/MIN(22)/W/15/Rev.2) related to the use of patent rights in the COVID-19 pandemic (the "Decision").
Introduction Of Foreign Investment Control In Switzerland – Federal Council Publishes Preliminary Draft Legislation - Inward/ Foreign Investment - Switzerland
As requested by Parliament, the Federal Council has published a preliminary draft legislation for consultation seeking to introduce foreign investment control in Switzerland. With the planned introduction of foreign investment control, Switzerland is following an international trend towards stricter regulation of foreign investments.
Swiss Federal Supreme Court Narrows The Scope Of The Agency Privilege - Antitrust, EU Competition - Switzerland
The Federal Supreme Court published its judgment regarding Les Editions Flammarion SA in the book market case and excludes the application of the agency privilege to exclusivity clauses partitioning the Swiss market. Investigation of the French-language book market Following an investigation opened by the Competition Commission ("Comco") in 2007, Les Editions Flammarion SA ("Flammarion") was sanctioned in 2013 along with 12 other distributors and diffusers.
ComCo Specifies New Rules On Market Power Effective As Of January 1, 2022
To print this article, all you need is to be registered or login on Mondaq.com. Shortly before the new rules in the Cartel Act on "relative market power" come into force, the Swiss competition authorities have published a guidance paper and a notification form on the new "relative market power" rules in Switzerland. Introduction In March 2021, Parliament adopted the counter-proposal to the so-called Fair Price Initiative.
Transactional issues with healthcare M&A in Switzerland | Lexology
Transactional issues Structures What is the typical structure of a healthcare-related business combination in your jurisdiction? The Swiss healthcare market is composed of a rich variety of companies in terms of size, organisation, development stage (research and development (R&D) and revenue-generating companies) and activities (drug products, medical devices, pharma and biotechnology). Many types of structures are used for healthcare-related business combinations.
Regulation of healthcare M&A in Switzerland | Lexology
Regulation Laws and regulations What are some of the primary laws and regulations governing or implicated in healthcare-related business combinations? Are healthcare assets subject to specific regulation that would be material in a typical transaction? Is law and regulation of healthcare national or subnational?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sevan
Contact Sevan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack